SV

Street Verdict

Analyst Scorecard

KIMS · NSE

Krishna Institute of Medical Sciences Limited

₹795.6

+3.62% (+₹27.8)

Prev. close

₹767.8

Volume

10,43,606

Delivery %

56.5%

As of

20 Nov 2026

Price history

₹795.6-₹9.9 (-1.23%) · 3M
18 Aug 2026 → 20 Nov 2026
68070072074076078080018 Aug09 Sept06 Oct29 Oct20 Nov
Daily closes · updates after each session

Analyst sentiment

No analyst stances in this range

0 analyst stances · last 90 days · one per analyst

Try a wider range.

Explore by date range →

Analyst opinions

CallAnalystInstrumentVerdictActions
Market commentary · 1 · levels, conditionals, previews, macro & hedged views — context, not graded
CallAnalystInstrumentVerdictActions

Fundamentals

About Krishna Institute of Medical Sciences Limited

Krishna Institute of Medical Sciences Limited provides medical and health care services under the KIMS Hospitals brand in India. The company offers arthroscopy and shoulder, cardiology, cardiothoracic and cardiovascular, organ transplant, medical and surgical gastroenterology, hepatology, orthopaedic, neurology, neurosurgery, nephrology, urology, oncology, pediatric, neonatology, obstetrics and gynaecology, fertility, dental science, emergency and critical care, vascular, rehabilitation and physiotherapy services. It also provides pulmonology, diagnostic and imaging, ophthalmology, ENT, rheumatology and clinical immunology, internal medicine, interventional radiology, diabetology, endocrinology, general surgery, infectious disease, dermatology, thoracic surgery, psychiatry, plastic and reconstructive surgery, transfusion medicine, clinical psychology, anesthesiology, and tele medicine services. In addition, the company operates clinical immunology allergy, bone marrow transplantation, hair transplant, andrology, fertility, alzheimer, arthroscopy, bone and joint, breast, dialysis, female urology, IUI, IVF, joint replacement, kidney health and transplant, ICU, spine, stroke, TAVR/TAVI, hepatobiliary surgery, and trauma centers, as well as pain and wellness clinics. Further, it provides bariatric, thoracic, oral maxillofacial, and endovascular surgery services. Krishna Institute of Medical Sciences Limited was incorporated in 1973 and is based in Secunderabad, India.

Details

Sector

Healthcare

Industry

Medical Care Facilities

CEO

Dr. Abhinay Bollineni

Headquarters

Secunderabad

Key stats

Market cap

₹31,103.58 Cr

P/E ratio (TTM)

145.2

Dividend yield

0.00%

EPS (TTM)

₹5.10

Beta (1Y · daily vs NIFTY 50)

0.75

Beta (5Y · monthly vs NIFTY 50)

0.85

Shares float

24.90 Cr

EPS · quarter ended Jun 2026

₹1.04

Financial Performance

01 · Financials

0 Cr1000 Cr2000 Cr3000 Cr4000 Cr₹0%10%20%30%FY21FY22FY23FY24FY25FY26
RevenueNet incomeEBITDANet income ÷ revenue

02 · Earnings Per Share (EPS)

02.557.510₹FY21FY22FY23FY24FY25FY26

04 · Operating Efficiency (Growth Rates)

Balance-sheet-based

0%25%50%75%100%FY21FY22FY23FY24FY25FY26
SalesFixed assetsTrade receivablesInventory

05 · Capital Structure & Asset Utilization

0 Cr2000 Cr4000 Cr6000 Cr8000 Cr₹0×0.5×1×1.5×2×FY21FY22FY23FY24FY25FY26
Total assetsTotal debtDebt / equityAsset turnover

Asset turnover needs a prior year of assets — omitted for the earliest available year.

06 · Asset Base Composition

0 Cr2000 Cr4000 Cr6000 Cr8000 Cr₹FY21FY22FY23FY24FY25FY26
Fixed assetsCurrent assetsOther assets

07 · Debt Level & Coverage

-2500 Cr0 Cr2500 Cr5000 Cr₹FY21FY22FY23FY24FY25FY26
DebtFree cash flowCash & equivalents

08 · Profit & Loss

Annual

Line itemFY21FY22FY23FY24FY25FY26
₹1,329.94 Cr₹1,650.83 Cr₹2,197.68 Cr₹2,498.14 Cr₹3,003.50 Cr₹3,904.60 Cr
EBITDA
₹381.05 Cr₹536.05 Cr₹644.71 Cr₹653.48 Cr₹824.00 Cr₹817.00 Cr
₹201.22 Cr₹332.69 Cr₹336.32 Cr₹310.15 Cr₹384.50 Cr₹241.40 Cr
Diluted EPS
₹5.24₹8.38₹8.41₹7.75₹9.61₹6.03

Total expenses (as filed), Employee benefit expense, Other expenses, Other income have filed figures for only some of the years shown — the missing years are left blank rather than estimated.

Net income for Mar 2021 could not be checked against the company's own annual report: this page shows ₹201.22 Cr while the annual report gives ₹205.48 Cr (2.1% apart).

09 · Balance Sheet

Annual

Line itemFY21FY22FY23FY24FY25FY26
₹1,433.00 Cr₹1,904.00 Cr₹2,901.00 Cr₹3,820.00 Cr₹5,689.00 Cr₹7,691.00 Cr
₹316.37 Cr₹256.53 Cr₹678.17 Cr₹1,355.50 Cr₹2,561.60 Cr₹4,252.90 Cr
Stockholders' equity
₹864.00 Cr₹1,387.00 Cr₹1,670.00 Cr₹1,828.00 Cr₹2,138.00 Cr₹2,247.00 Cr

CWIP, Others, Long-term debt, Current (short-term) debt have filed figures for only some of the years shown — the missing years are left blank rather than estimated.

Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.

10 · Cash Flow Statement

Annual

Line itemFY21FY22FY23FY24FY25FY26
₹355.97 Cr₹520.12 Cr₹432.09 Cr₹521.09 Cr₹581.80 Cr₹510.80 Cr
Investing cash flow
₹-354.18 Cr₹-606.48 Cr₹-546.89 Cr₹-752.56 Cr₹-1,116.20 Cr₹-1,451.70 Cr
₹9.82 Cr₹59.87 Cr₹19.64 Cr₹216.76 Cr₹543.10 Cr₹940.30 Cr
Capital expenditure
₹-94.00 Cr₹-170.00 Cr₹-575.00 Cr₹-647.00 Cr₹-1,009.00 Cr₹-1,428.00 Cr
End cash position
₹52.13 Cr₹25.63 Cr₹61.61 Cr₹46.89 Cr₹56.00 Cr₹55.40 Cr

Debt issued, Debt repaid, Dividends paid have filed figures for only some of the years shown — the missing years are left blank rather than estimated.

Annual only — the data source has no quarterly cash-flow-statement coverage.

11 · Shareholding Pattern

NSE, quarterly

Line itemJun 21Sep 21–Sep 23(9Q)Dec 23–Mar 25(6Q)Jun 25–Mar 26(4Q)Jun 26–Jun 26(2Q)
Promoter38.85%38.84%38.82%34.11%32.50%
Public61.15%61.16%61.18%65.89%67.50%
Employee trusts0.00%0.00%0.00%0.00%0.00%

Source: NSE quarterly shareholding-pattern filings, collapsed to periods where the reported percentages held steady — a column spanning several quarters means no change was filed across them. No FII/DII sub-split available from this source — Public includes all non-promoter, non-employee-trust holders.

12 · Peer Comparison

Healthcare

Company
Sun Pharmaceutical Industries Limited₹4.25 L Cr₹1,769.938.85.0913.7%0.06+11.9%+3.7%
Divi's Laboratories Limited₹2.66 L Cr₹10,037.590.815.8515.3%0.00+12.3%+47.5%
Torrent Pharmaceuticals Limited₹1.79 L Cr₹4,738.579.421.3125.8%1.79+21.5%+32.5%
Laurus Labs Limited₹1.27 L Cr₹2,34894.823.9416.8%0.48+22.0%+146.2%
Apollo Hospitals Enterprise Limited₹1.23 L Cr₹8,599.558.812.9520.5%0.90+15.7%+10.1%
Zydus Lifesciences Limited₹1.19 L Cr₹1,188.126.74.4018.6%0.46+18.4%+22.3%
Lenskart Solutions Limited₹1.16 L Cr₹689.7181.413.305.6%0.35+35.4%—
Dr. Reddy's Laboratories Limited₹1.14 L Cr₹1,37440.63.0211.4%0.21+3.2%+14.5%
Cipla Limited₹1.13 L Cr₹1,40238.93.2711.3%0.02+2.1%-6.7%
Mankind Pharma Limited₹1.03 L Cr₹2,47545.96.3111.7%0.39+17.0%+3.1%
Aurobindo Pharma Limited₹98,101.93 Cr₹1,70526.62.599.2%0.21+6.4%+48.4%
Krishna Institute of Medical Sciences Limited₹30,681.47 Cr₹740.55143.213.6510.7%1.89+28.9%+3.3%

Ranked by market cap within Healthcare, same metrics as the Fundamentals screener. Click a column to sort.

Documents

Official documents linked from their sources — offer documents as filed with SEBI (sebi.gov.in), annual reports and earnings-call transcripts as published on BSE (bseindia.com) and NSE (nseindia.com). Links open the source's own hosting; nothing is re-hosted here.

KIMS

Krishna Institute of Medical Sciences (NSE: KIMS) Q2 FY27 Results: Revenue Growth and Margin Trends

Kalkine India · 2 days ago

KIMS

KIMS: The Growth Story Now Needs a Profit Recovery

Moneylife · 10 days ago